These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13567528)

  • 1. [Study of the plasma proteins in multiple sclerosis; attempted biological and clinical correlation in 63 cases, of which 30 have been treated with delta-cortisone for 2 years].
    CLAISSE R; HARTMANN L; ANDREOLI G
    Presse Med (1893); 1958 Jun; 66(48):1086-8. PubMed ID: 13567528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cortisone therapy of multiple sclerosis].
    ALAJOUANINE T; CASTAIGNE P; LHERMITTE F
    Rev Neurol (Paris); 1956 Apr; 94(4):352. PubMed ID: 13390238
    [No Abstract]   [Full Text] [Related]  

  • 3. On the occurrence of proteolipids in plasma in multiple sclerosis.
    Ketelaer CJ; Delmotte P
    Acta Neurol Psychiatr Belg; 1966 Apr; 66(4):270-3. PubMed ID: 4958946
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cortisone treatment in multiple sclerosis; comparison with other treatment methods].
    OTT B
    Nervenarzt; 1958 Jan; 29(1):33-5. PubMed ID: 13517457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Electrophoretic fractionation of blood proteins in multiple sclerosis].
    DELMAR A; RIVENSON JT
    Prensa Med Argent; 1958 Jan; 45(1):75-81. PubMed ID: 13567392
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience of ACTH and cortisone treatment in some organic neurological cases.
    JONSSON B; VON REIS G; SAHLGREN E
    Acta Psychiatr Neurol Scand Suppl; 1951; 74():60-5. PubMed ID: 14902541
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein and lipide studies in multiple sclerosis.
    ROBOZ E; HESS WC; TEMPLE DM; FORSTER FM
    Trans Am Neurol Assoc; 1954; 13(79th Meeting):211-4. PubMed ID: 13238366
    [No Abstract]   [Full Text] [Related]  

  • 8. [The behavior of blood protein fractions in multiple sclerosis].
    DANIELCZYK W; KRIVANEC E
    Wien Klin Wochenschr; 1954 Jul; 66(29):512-6. PubMed ID: 13205961
    [No Abstract]   [Full Text] [Related]  

  • 9. The protein profile in multiple sclerosis.
    RABINER AM; SAIFER A; VOLK BW
    Trans Am Neurol Assoc; 1954; 13(79th Meeting):208-10. PubMed ID: 13238364
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trials of therapy of multiple sclerosis based on pathogenetic aspects].
    TSCHABITSCHER H; SLUGA-GASSER E; SCHINKO H
    Wien Z Nervenheilkd Grenzgeb; 1958; 15(1-4):326-56. PubMed ID: 13604315
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with corticoid long-term therapy in multiple sclerosis].
    Muller E; Kostakopoulos M
    Med Welt; 1967 Mar; 9():485-91. PubMed ID: 5584097
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma S100beta and NSE levels and progression in multiple sclerosis.
    Koch M; Mostert J; Heersema D; Teelken A; De Keyser J
    J Neurol Sci; 2007 Jan; 252(2):154-8. PubMed ID: 17187827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood proteins in multiple sclerosis].
    WENDER M; PATELSKI J; FILIPEK H
    Neurol Neurochir Psychiatr Pol; 1957; 7(6):913-22. PubMed ID: 13541576
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
    Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
    Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum potassium in multiple sclerosis treated with berolase (cocarboxylase)].
    ERVENICH P; KRUEGER R
    Arztl Forsch; 1955 Apr; 9(4):I/189-94. PubMed ID: 14387848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mental disorders associated with multiple sclerosis].
    Wilkening A; Haltenhof H
    Dtsch Med Wochenschr; 2006 Jan; 131(4):154-8. PubMed ID: 16429337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic dropsy, Nadiad epidemic; observations on serum proteins and cortisone therapy.
    SHAH MJ; LEWIS RA
    J Indian Med Assoc; 1955 Jan; 24(7):245-8. PubMed ID: 13233532
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of massive doses of cortisone: study of the metabolism and of the biological properties of cortisone in leukosis treated with massive doses of cortisone.
    DELTOUR G; WEINMANN S; BILSKIPASQUIER G; BERNARD J
    Sem Hop; 1955 Mar; 31(20):1141-9. PubMed ID: 14373035
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis.
    Bagnato F; Durastanti V; Finamore L; Volante G; Millefiorini E
    Neurol Sci; 2003 Dec; 24 Suppl 5():S301-4. PubMed ID: 14652795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood plasma in multiple sclerosis; periodic abnormalities of paper chromatograms.
    SWANK RL
    AMA Arch Neurol Psychiatry; 1953 Mar; 69(3):281-92. PubMed ID: 13029964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.